Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Prostate Cancer: Can it Be 100% Cured?
Prostate Cancer: Can it Be 100% Cured? 4

Did you know prostate cancer is a common cancer among men? It affects thousands worldwide each year. Thanks to new medical technology and treatments, the outlook for men with this disease has gotten much better. Prostate cancer is highly treatable. Discover amazing facts about full recovery and how to find a powerful cure for your specific stage.

Understanding prostate cancer and its treatment is key for patients. The Gleason score helps doctors know how aggressive the cancer is. This helps them create the best treatment plan for each patient. Spotting the signs and symptoms early can also make treatments more effective.

Key Takeaways

  • Prostate cancer is a common condition among men, but treatment outcomes have improved significantly.
  • The Gleason score is critical in figuring out how aggressive the disease is.
  • Spotting signs and symptoms early is key for effective treatment.
  • Knowing about treatment options helps patients make better choices.
  • New medical technology has made treatments more effective.

Understanding Prostate Cancer Types

Prostate Cancer: Can it Be 100% Cured?
Prostate Cancer: Can it Be 100% Cured? 5

Prostate cancer comes in several types, each with its own traits and treatment needs. Understanding these differences is essential for determining the appropriate treatment options.

Adenocarcinoma vs. Other Types

Prostate cancer types are based on cell origin and histological characteristics. The most common is adenocarcinoma, making up most cases. It starts in the glandular cells of the prostate.

Other types are less common but include:

  • Small cell carcinoma
  • Neuroendocrine tumors
  • Sarcomas
  • Transitional cell carcinomas

Each type has its own features and might need different treatments.

Staging and Grading of Prostate Cancer

Adenocarcinoma’s aggressiveness is measured by the Gleason grading system. The Gleason score ranges from 2 to 10. A lower score means less aggressive cancer, while a higher score means more aggressive.

Staging prostate cancer means finding out how far it has spread. The TNM system is commonly used. It looks at tumor size (T), lymph node involvement (N), and metastasis (M).

Stage

Description

T1

Tumor is incidental, not palpable or visible by imaging

T2

Tumor is confined within the prostate

T3

Tumor extends through the prostate capsule

T4

Tumor is fixed or invades adjacent structures

Grading and staging help predict outcomes and guide treatments. Knowing prostate cancer symptoms and the types and stages is essential for managing the disease effectively.

Risk Factors for Prostate Cancer

Prostate Cancer: Can it Be 100% Cured?
Prostate Cancer: Can it Be 100% Cured? 6

Prostate cancer risk comes from age, genetics, and lifestyle. Knowing these factors helps in prevention and early detection.

Age, Genetics, and Ethnicity

Age is a big risk factor for prostate cancer. The risk grows after 50. Men with a family history of prostate cancer face higher risks, too.

Genetic mutations like in BRCA1 and BRCA2 genes raise the risk. Men with these should talk to their doctors about their risk.

African American men are more likely to get prostate cancer. The exact reasons are unclear, but genetics and environment play parts.

Diet and Lifestyle Influences

Diet and lifestyle choices affect prostate cancer risk. Eating fruits, vegetables, and whole grains is good. But, eating too much processed meat and dairy might raise the risk.

  • Eating well can lower the risk.
  • Staying active is also good.
  • Keeping a healthy weight is key for health.

Health experts say, “A healthy lifestyle can help lower prostate cancer risk. But it can’t remove it completely.”

For more on signs of prostate cancer and early detection, talk to your doctor. Knowing the risks and taking steps can greatly improve prostate cancer treatment chances.

Symptoms and Early Detection

Knowing the symptoms of prostate cancer can help find it early. Early prostate cancer often has no symptoms. But knowing the signs can lead to getting checked by a doctor.

Common Symptoms to Watch For

As prostate cancer grows, it can cause different symptoms. These include:

  • Difficulty urinating or a weak urine flow
  • Frequent urination, often at night
  • Blood in the urine or semen
  • Pain or stiffness in the hips, pelvis, or thighs

These symptoms can also mean other health issues like prostatitis or BPH. But, seeing a doctor is key if you notice any of these signs.

Importance of Regular Screenings

Regular tests are key to finding prostate cancer early. Tests like the PSA test and DRE can spot cancer before symptoms show.

Early detection through regular screenings can greatly improve treatment results. It means treatments can be less harsh and survival chances better.

Talk to your doctor about prostate cancer screening. They can help decide what’s best for you.

Diagnosing Prostate Cancer

Learning about prostate cancer diagnosis can ease worries and help patients understand their treatment path. Diagnosing prostate cancer requires several tests and procedures. These help find out if the disease is present and how far it has spread.

PSA Testing: What You Need to Know

PSA testing is a common way to check for prostate cancer. It measures PSA levels in the blood. High levels might mean cancer, but other issues can also cause them.

  • Understanding PSA Levels:
  • Normal PSA levels are usually 4 ng/mL or less.
  • Levels between 4 and 10 ng/mL are borderline. Decisions on further testing depend on age, family history, and ethnicity.
  • Levels over 10 ng/mL are high. More tests are usually needed.

Biopsy Procedures Explained

If PSA or DRE tests suggest cancer, a biopsy is done to confirm. A biopsy takes a sample of prostate tissue. It’s then checked for cancer cells under a microscope.

  • Types of Biopsy:
  • Transrectal Ultrasound-Guided Biopsy: Uses ultrasound to guide the needle into the prostate.
  • Transperineal Biopsy: The needle is inserted through the perineum, between the scrotum and anus.

Gleason Score: After the biopsy, the tissue is graded. The Gleason score ranges from 2 to 10. A higher score means the cancer is more aggressive.

Gleason Score

Cancer Aggressiveness

Typical Treatment Approach

2-6

Low to moderate

Active surveillance or surgery

7

Moderate to high

Surgery or radiation therapy

8-10

High

Aggressive treatment, including radiation and hormonal therapy

“Radical” in prostate cancer treatment often means radical prostatectomy. This surgery removes the prostate gland. It’s often used for localized prostate cancer.

Treatment Options for Prostate Cancer

Today, there are many ways to treat prostate cancer. The right treatment depends on the cancer’s stage, grade, and the patient’s health. It also depends on what the patient prefers.

Surgery: Types and Risks

Surgery is a common choice for treating prostate cancer. It’s often used when the cancer is in its early stages. The main surgery is called a radical prostatectomy. This means removing the prostate gland and some nearby tissue.

There are different surgeries, including:

  • Open radical prostatectomy
  • Laparoscopic radical prostatectomy
  • Robotic-assisted laparoscopic prostatectomy

Each surgery has its own benefits and risks. For example, robotic-assisted surgery is very precise. It might have fewer complications. But, it’s not available everywhere.

Surgical Approach

Benefits

Risks

Open Radical Prostatectomy

Effective for removing cancer, widely available

Higher risk of complications, longer recovery

Laparoscopic Radical Prostatectomy

Less invasive, quicker recovery

Steeper learning curve for surgeons, potentially fewer lymph nodes removed

Robotic-Assisted Laparoscopic Prostatectomy

High precision, potentially fewer complications

Expensive, not universally available

Radiation Therapy: Techniques and Efficacy

Radiation therapy is another effective way to treat prostate cancer. It uses high-energy rays to kill cancer cells. There are two main types: external beam radiation therapy (EBRT) and brachytherapy.

EBRT sends radiation from outside the body to the prostate gland. Newer EBRT methods are more effective and have fewer side effects.

Brachytherapy places radioactive seeds inside the prostate. This method delivers a high dose of radiation right to the cancer. It helps protect the surrounding tissues.

Hormonal Therapy: How It Works

Hormonal therapy, or androgen deprivation therapy (ADT), lowers male hormones that help cancer grow. This can be done with medicines or surgery.

It’s used in several ways:

  1. To shrink the cancer before other treatments
  2. To control cancer that has spread
  3. To ease symptoms

While it works well, hormonal therapy can cause side effects. These include hot flashes, osteoporosis, and changes in body shape.

Every patient is different, and treatments are customized. Knowing the options is key to making informed choices about prostate cancer care.

Advanced Treatment Strategies

New ways to fight prostate cancer are changing the game. Research is finding new ways to target this disease. Now, treatments are more tailored and precise.

Immunotherapy: Emerging Techniques

Immunotherapy uses the body’s immune system to fight cancer. It includes methods like checkpoint inhibitors and cancer vaccines. Checkpoint inhibitors help the immune system attack cancer cells better.

“, a leading researcher in the field. “Immunotherapy offers a promising avenue for patients who have not responded to traditional treatments.”

Targeted Therapies: What’s Available?

Targeted therapies are another big step forward. They aim at specific molecules in cancer cells, sparing normal cells. PARP inhibitors, for example, are good for cancers with certain genetic changes.

  • PARP inhibitors for cancers with BRCA1 and BRCA2 mutations
  • Androgen receptor inhibitors for advanced prostate cancer

Prognosis of Prostate Cancer

The outlook for prostate cancer changes a lot based on when it’s found and other personal factors. Knowing these details is key for both patients and doctors to choose the best treatment and care.

Survival Rates by Stage

How long someone lives with prostate cancer depends a lot on when it’s found. Early detection means a better chance of beating the disease.

  • Localized Prostate Cancer: Found early, the 5-year survival rate is almost 100%.
  • Regional Prostate Cancer: Cancer that has spread a bit nearby also has a high 5-year survival rate, around 100%.
  • Distant Prostate Cancer: But, if cancer spreads far, the 5-year survival rate drops to about 31%.

Factors Influencing Prognosis

Many things affect how well someone does with prostate cancer, like the Gleason score, PSA levels, and overall health.

The Gleason score is very important. A higher score means the cancer is more aggressive, needing stronger treatments.

PSA levels and overall health also matter a lot. Higher PSA levels often mean more advanced cancer.

For example, someone with early-stage cancer and a low Gleason score might do very well with treatments like surgery or radiation. But, someone with advanced cancer and a high Gleason score might face tougher challenges. They might need treatments like hormone therapy and chemotherapy.

In short, the outlook for prostate cancer depends on many things like stage, grade, and personal factors. Understanding these helps doctors create better treatment plans for their patients.

The Role of Clinical Trials

Clinical trials are key for prostate cancer patients looking for new treatments. They help advance treatment options and deepen our understanding of cancer.

Importance of Research in Treatment

Research is critical for finding better prostate cancer treatments. Clinical trials show how treatments work and what side effects they might have.

“The development of effective treatments for prostate cancer relies heavily on the insights gained from clinical trials and research into cancer biology.”

Clinical trials have different phases, each with its own goal:

  • Phase I: Safety and dosage
  • Phase II: Efficacy and side effects
  • Phase III: Comparison with existing treatments

How to Participate in Clinical Trials

Joining a clinical trial is a big choice for prostate cancer patients. To join, patients must meet certain criteria. This includes the cancer stage, past treatments, and overall health.

Eligibility Criteria

Description

Cancer Stage

Specific stages of prostate cancer

Previous Treatments

History of treatments received

Overall Health

Patient’s general health condition

Patients can find trials through their doctor, online at , or by contacting research centers.

Managing Side Effects of Treatment

Prostate cancer treatment can cause significant side effects. It’s important for patients to know what to expect and how to handle these effects. We will look at the different treatment options and their side effects, focusing on how they affect patients’ lives.

Physical Side Effects to Expect

Physical side effects of prostate cancer treatment vary by treatment type. Common ones include urinary incontinence, erectile dysfunction, and fatigue. We will explore ways to manage these side effects to enhance patients’ well-being.

Urinary incontinence can be managed with pelvic floor exercises. Erectile dysfunction may be treated with medication or other methods. Fatigue can be reduced by eating well and exercising regularly.

Physical Side Effect

Management Strategy

Urinary Incontinence

Pelvic floor exercises, lifestyle modifications

Erectile Dysfunction

Medication, counseling, lifestyle changes

Fatigue

Balanced diet, regular exercise, rest

Emotional and Psychological Impact

The emotional and psychological effects of prostate cancer treatment are significant. Patients may feel anxious, depressed, or stressed. We highlight the need for emotional support and offer resources to help manage these challenges.

Counseling, support groups, and stress management are key in coping with treatment’s emotional aspects. Recognizing the emotional and psychological impact allows us to provide better care.

Understanding and managing prostate cancer treatment side effects is vital. By addressing both physical and emotional challenges, we aim to improve the quality of life for those affected by prostate cancer.

Support Systems for Patients and Families

When prostate cancer hits, it impacts not just the person but their loved ones too. It’s a tough journey, both physically and emotionally. A strong support system can really help patients and their families stay strong.

Importance of Community Support

Community support is key for those dealing with prostate cancer. It can take many forms, like support groups, counseling, and online forums. Being part of a community that gets it can offer comfort and advice.

Support groups, online or in-person, are great for sharing stories and getting support. Counseling helps with the emotional side of diagnosis and treatment. Online forums and resources provide info and connections worldwide.

Resources for Caregivers

Caregivers play a big role in supporting prostate cancer patients. But they face their own challenges, like emotional stress and care duties. It’s important for them to have resources to help them in their role.

Resources for caregivers include training, emotional support, and respite care. Organizations focused on prostate cancer often offer specific help for caregivers.

Resource Type

Description

Benefit

Support Groups

In-person or online groups for sharing experiences

Emotional support, practical advice

Counseling Services

Professional guidance on coping with diagnosis and treatment

Coping strategies, emotional support

Online Forums

Platforms for connecting with others worldwide

Information sharing, global support network

Caregiver Training

Training on patient care and management

Improved care quality, reduced caregiver stress

In conclusion, a strong support system is essential for prostate cancer patients and their families. By using community support and caregiver resources, people can face the challenges of prostate cancer better.

The Future of Prostate Cancer Treatment

The future of prostate cancer treatment is looking bright. New technologies and methods are being explored. These aim to make treatments better for patients.

Emerging Technologies in Prostate Cancer

Single-cell analysis is a big step forward. It helps us understand the different types of prostate cancer. By studying each cancer cell, doctors can create treatments that fit each patient’s needs, even for those with high Gleason scores.

Personalized Medicine: A New Era

Personalized medicine is changing how we treat prostate cancer. It lets doctors create treatment plans that match each patient’s unique genetic makeup. This could make treatments more effective and reduce side effects, improving patients’ lives.

As research keeps moving forward, we’ll see even better treatments for prostate & cancer. This brings hope to patients and their families.

FAQ

What is the Gleason score and how is it used in prostate cancer diagnosis?

The Gleason score grades prostate cancer based on tumor tissue appearance. It ranges from 2 to 10, with higher scores meaning more aggressive cancer. This score helps us choose the best treatment.

What are the common signs and symptoms of prostate cancer?

Symptoms include trouble urinating, weak urine flow, and frequent need to urinate. Pain in the back, hips, or chest can also occur. Regular screenings help catch prostate cancer early.

What are the different types of prostate cancer?

Adenocarcinoma is the most common type, making up about 90% of cases. Other types include small cell carcinoma and sarcomas. Knowing the type helps us decide the best treatment.

How is prostate cancer staged and graded?

Staging shows how far the cancer has spread. Grading uses the Gleason score to measure cancer aggressiveness. We use both to plan treatment and predict outcomes.

What are the risk factors for developing prostate cancer?

Risk factors include age, family history, and diet. Men over 50 and those with a family history should be careful. We can assess your risk and suggest preventive steps.

How is prostate cancer diagnosed?

Diagnosis uses PSA tests, digital rectal exams, and biopsies. Imaging tests like MRI or CT scans help stage the cancer. Accurate diagnosis is key for effective treatment.

What are the treatment options for prostate cancer?

Options include surgery, radiation, hormonal therapy, and active surveillance. We tailor treatment to your cancer stage, health, and preferences.

What is the role of immunotherapy in prostate cancer treatment?

Immunotherapy uses the body’s immune system to fight cancer. It’s being explored for advanced prostate cancer and offers new hope.

How do clinical trials contribute to prostate cancer research?

Clinical trials help develop new treatments and improve existing ones. They offer access to innovative therapies and help us understand what works best for patients.

What are the common side effects of prostate cancer treatment?

Side effects include urinary incontinence, erectile dysfunction, and fatigue. We help manage these side effects to improve your quality of life.

Why is community support important for prostate cancer patients?

Community support provides emotional and practical help. It’s essential for coping with the disease. We encourage patients to connect with support groups and resources.

What is the future of prostate cancer treatment?

The future is promising with advancements in personalized medicine and immunotherapy. We are committed to staying at the forefront of these developments to offer the best care.

References

National Center for Biotechnology Information. Evidence-Based Medical Insight. Retrieved from https://pubmed.ncbi.nlm.nih.gov/40892160/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 42 01